Ziraoui N-E, Salazar M, Kensington A. BCLC™ NAD⁺ Supplement System Targeting SIRT1: A Time-Sequential Biphasic NMN-Resveratrol-Quercetin Formulation with Supporting Clinical and Pharmacological Evidence. IJPHMR [Internet]. 2026 Apr. 29 [cited 2026 Apr. 29];6(4):36-44. Available from: https://wepub.org/index.php/IJPHMR/article/view/6100